Last reviewed · How we verify

NCT04223700

Ultrasound-guided Thoracic Spinal Level Identification

Status unknown NA Last updated 10 January 2020
What this trial tests

NA trial testing Ultrasound imaging & fluoroscopic confirmation in Thoracic Diseases in 100 participants. Status unknown.

Timeline
13 January 2020
Primary endpoint
15 December 2021
15 December 2021

Quick facts

Lead sponsorSeoul National University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date13 January 2020
Primary completion15 December 2021
Estimated completion15 December 2021

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University

Who can join

Adults 19 to 85, any sex, with Thoracic Diseases or Myofascial Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Typically, the rhomboid minor muscles rise from the C7-T1 spinous process and run downward to touch the upper inner corner of the scapula, and the rhomboid major muscles rise from the T2-T5 spinous process and run downward to reach the lower middle inner corner of the scapula. In anatomical research articles, it has been reported that the rhomboid muscle's anatomical variations are rare. Considering the characteristics of these rhomboid muscles, the investigators planned a study on the utility of rhomboid muscles as a landmark for identifying thoracic spine levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Thoracic Diseases

Currently open trials in the same condition.

Other Seoul National University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04223700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing